Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 30Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Classical hematology 2Sarcoma 1Other 1

Conditions

Obesity 298Mucositis 116Neoplasms 108Breast Neoplasms 87Overweight 80Sexual Dysfunction, Physiological 74Polycystic Ovary Syndrome 71Dyspnea 48Motor Activity 46Constipation 45Head and Neck Neoplasms 42Weight Loss 36Prostatic Neoplasms 32Pain 29Stomatitis 26Endometrial Neoplasms 23Opioid-Induced Constipation 21Multiple Endocrine Neoplasia Type 1 20Diabetes Mellitus 20Lung Neoplasms 18Colorectal Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Sexual Dysfunctions, Psychological 15Depression 15Cardiovascular Diseases 15Anxiety Disorders 15Sedentary Behavior 13Insulin Resistance 13Infertility 13Cancer-related Fatigue 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Inflammatory Bowel Diseases × Other × Clear all
NCT04633512 2024-02-21

Safety and Feasibility of ActivSightTM in Human

Activ Surgical

Phase NA Unknown
67 enrolled
GastrointestinalOther

Diverticulitis, Colonic, Obesity, Morbid, Colorectal Neoplasms, Inflammatory Bowel Diseases, Cholecystitis, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡